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Recently, the presence of lymphatics has been demonstrated and characterized in the
dura mater, which is in contrast to the well-accepted view indicating the lack of a
classical lymphatic drainage system of the central nervous system (CNS). Moreover,
the role of meningeal lymphatics in the pathogenesis of Alzheimer’s disease and
multiple sclerosis was suggested. However, the possible regulators of the developmental
program and function of meningeal lymphatics remain unclear. Here, we aimed at
characterizing the lymph flow dependence of the developmental program and function
of the meningeal lymphatics. First, we demonstrated that lymphatics present in the
dura mater are involved in the uptake and transport of macromolecules from the CNS.
Meningeal lymphatics develop during the postnatal period which process involves the
maturation of the vessels. The formation of mature meningeal lymphatics coincides
with the increase of the drainage of macromolecules from the CNS to the deep
cervical lymph nodes. Importantly, the structural remodeling and maturation of meningeal
lymphatics is impaired in Plcγ2−/− mice with reduced lymph flow. Furthermore,
macromolecule uptake and transport by the meningeal lymphatics are also affected
in Plcγ2−/− mice. Collectively, lymph flow-induced mechanical forces are required for
the postnatal formation of mature and functional meningeal lymphatic vessels. Defining
lymph flow-dependence of the development and function of meningeal lymphatics may
lead to better understanding of the pathogenesis of neurological diseases including
Alzheimer’s disease and multiple sclerosis.
Keywords: lymphatics, meninges, developmental program, lymphatic function, lymph flow, central nervous
system, macromolecule transport
INTRODUCTION
Until recently, the classical, well-accepted view was that the central nervous system (CNS) lacks
lymphatic structures (1). However, sporadic studies suggested the presence of lymphatic vessels
in the dura mater. The first known report about the presence of meningeal lymphatic structures
was published in 1787 by Mascagni, which was followed by others during the previous decades
(2–5). However, these early studies were not able to change the classical view. In 2015 two parallel
studies described the presence of lymphatic structures in the dura mater in mouse models (6, 7).
In addition, the meningeal lymphatics were shown in non-human primates and humans, in which
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the morphological characteristics of these lymphatic vessels were
very similar to the structure of meningeal lymphatics in rodents
(8, 9). Importantly, the latest studies using mouse models showed
the possible role of meningeal lymphatics in the pathogenesis
of neurological diseases affecting the CNS including Alzheimer’s
disease and neuroinflammatory diseases such as multiple
sclerosis (10–14). These studies suggested the importance of
meningeal lymphatics not only under physiological conditions
but also in the pathophysiology of the CNS.
It is known that macromolecules are drained to the deep
cervical lymph nodes from the CNS (6, 7, 15–17). The classical
concept of the possible drainage routes to the cervical region
is that macromolecules and immune cells leave the CNS via
the cribriform plate and in the wall of the incoming and
outgoing blood vessels and nerves of the brain (18). Recent
studies suggested that meningeal lymphatic vessels are involved
(or might be involved) in the transport of macromolecules and
immune cells from the CNS (6, 7, 10, 11, 19). In parallel, another
report demonstrated that macromolecules injected into the CNS
are drained to the deep cervical lymph nodes via several different
transport routes including the paravascular space of the pia mater
and perineural routes (e.g., next to the optic nerve), but the
involvement of meningeal lymphatics in the uptake and transport
of macromolecules from the CNS was unclear based on their
work (20).
It has recently been revealed that meningeal lymphatics
develop during the postnatal period, and the Vascular
endothelial growth factor C (VEGFC)—Vascular endothelial
growth factor receptor 3 (VEGFR3) signaling axis, similarly
to the developmental program in other organs including the
gastrointestinal tract, is required for the development and
structural maintenance of these vessels (21–23). However, the
possible other regulators of the developmental program and
function of meningeal lymphatics remain unclear.
Maintaining lymph flow is critical for mediating the functions
of the lymphatic system including fluid transport, uptake of
macromolecules from the interstitial compartment and immune
cell trafficking (24, 25). It has been established that mechanical
forces generated by fluid shear stress regulate gene expression
and lymph vessel formation in vitro by their direct effect on
lymphatic endothelial cells (LECs) (26). The in vivo importance
of mechanical forces in lymphatic growth and function is
also suggested by human data because patients who carry
mutations in the PIEZO1 mechanosensor protein expressed
on the surface of LECs develop primary lymphedema (27,
28). Moreover, genetic studies in mouse models revealed
the importance of PIEZO1-induced mechanical forces in the
development and maintenance of lymphatics (29, 30). These
reports indicate the importance and function of mechanical
Abbreviations: CLEC2, C-type lectin domain family 1 member B; CNS, Central
nervous system; E, Embryonic day; LEC, Lymphatic endothelial cell; LYVE-
1, Lymphatic vessel endothelial hyaluronan receptor 1; P, Postnatal day; PBS,
Phosphate buffered saline; PDPN, Podoplanin; PECAM, Platelet endothelial cell
adhesion molecule; PFA, Paraformaldehyde; PLCγ2, Phospholipase C γ 2; PROX-
1, Prospero homeobox 1; RhD, Rhodamine dextran; VEGFR3, Vascular endothelial
growth factor receptor 3; VEGFC, Vascular endothelial growth factor C; WT,
Wild type.
forces in lymphatic development, but defining the role of lymph
flow-induced mechanical forces has great limitations in in
vivo experiments.
In mouse models lacking the components of the CLEC2, SYK,
SLP76 signaling axis in platelets backflow of blood is present
from the venous system into the lymphatic vasculature, which
phenotype develops because of the loss of platelet activation
by LECs at the lympho-venous junction, where the thoracic
duct meets the subclavian vein (31–33). It is known that
PLCγ2 is a member of the same signaling pathway, in addition
PLCγ2-deficient mice exhibit similar phenotype (blood-filled
lymphatics in embryos), which is present in CLEC2-deficient,
SYK-deficient and SLP76-deficient animals (31–35). Prior studies
used CLEC2-deficient mice to demonstrate the role of lymphatic
function and lymph flow for inducing the structural remodeling
of the mesenteric lymphatics during the development of the
system, which process involves the maturation of these lymphatic
structures (25, 36). Moreover, in a recent report CLEC2-deficient
mouse strain with reduced lymphatic function was also applied
as an in vivo model to define the role of pulmonary lymphatics
in the postnatal lung (37). It is thought that as CLEC2-deficient
mice which were used in previous reports to characterize
the importance of lymph flow and lymphatic function in the
gastrointestinal tract and lungs, the PLCγ2-deficient system can
be a perfect model to define the possible role of lymph flow in
the other organs in vivo (25, 36, 37). It is yet to be established
whether lymph flow-generated mechanical forces are involved in
the morphogenesis of the lymphatic vasculature in other organs
including the lymphatic vessels of the dura mater.
Here, we aimed at characterizing the lymph flow
dependence of the developmental program and function
of the meningeal lymphatics. Using genetic models we
demonstrated that meningeal lymphatics present in the
dura mater are involved in the uptake and transport of
macromolecules injected into the CNS. Lymph flow mediated
maturation of meningeal lymphatics occurs during the postnatal
period, which process coincides with the increase of the
drainage of macromolecules from the CNS. Importantly,
our studies using PLCγ2-deficient mice revealed that
lymph flow-induced mechanical forces are required for the
postnatal formation of mature and functional meningeal
lymphatic vessels.
MATERIALS AND METHODS
Animals
Male and female C57BL/6 wild type (purchased from commercial
sources), Prox1GFP obtained from the Mutant Mouse Regional
Resource Centers (MMRRC) and Flt4YFP generously provided
by Jean-Léon Thomas (INSERM, France) lymphatic endothelial
cell reporter mice were used (38, 39). Prox1GFP mice were
maintained in heterozygous form and genotyped by a transgene-
specific PCR using 5′-GATGTGCCATAAATCCCAGAGCCT
AT−3′ forward and 5′-GGT CGG GGT AGC GGC TGA A−3′
reverse primers, Flt4YFP mice were bred in heterozygous form,
and genotyped by transgene-specific PCR primer sets including
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5′-GGA TCA CTC TCG GCA TGG AC−3′ forward and 5′-GGG
CGT CCT CAT ACC TAG GT−3′ reverse primers.
To study the possible role of lymphatic function and lymph
flow we used Plcγ 2−/− [generously provided by James Ihle
(St. Jude Children’s Research Hospital) (34)] and littermate
control mice. The strain was maintained in heterozygous form
and genotyped by allele-specific PCR reaction using 5′-GCC
TCT GCA CAG CAC ACA TAT GG−3′ WT-specific and 5′-
CAA GGT GAG ATG ACA GGA GAT CC−3′ mutant-specific
forward primers along with the 5′-TTC ACC GCA TCC TCC
TTT GAG TCC−3′ common reverse primer.
Experimental animals were housed in either specific pathogen
free or conventional animal facilities. All animal experiments
were approved by the Animal Experimentation Review Board of
the Semmelweis University and the Government Office for Pest
County (Hungary).
Tissue Isolation and Fixation
To study the developmental program of the meningeal
lymphatics, mice at different ages [from postnatal day 0 (P0)
to P21] were used. The procedure for meninges isolation was
based on the protocol of Louveau and Kipnis as described before
(6, 40). Briefly, adult mice and pups older than P8 were perfused
with 10ml of Phosphate buffered saline (PBS) followed by 10ml
of 4% paraformaldehyde (PFA). Pups between P0 and P8 were
perfused with 5ml of PBS followed by 5ml of 4% PFA. Using
angled scissors, skin and muscles were removed from the skull
followed by the dissection of optic nerves, eyeballs, mandibles,
and muscles connecting to the lower jaw. After that the lower
orbits and nasal bone were cut and the lower portion of the skull
was removed. Meninges attached to the skull cap were then fixed
in 4% PFA overnight at 4◦C and washed in PBS.
For histological analysis dissected lymph nodes were fixed
overnight in 4% PFA and washed in PBS followed by a paraffin-
based histology protocol.
Histology Procedures and Immunostaining
of Histology Slides
For histological analysis, fixed lymph nodes were dehydrated in
100% ethanol and embedded in paraffin (Leica) using a Leica
EG1150 tissue embedder. 7-µm-thick sections using a HM340E
Thermo Scientific microtome were processed for hematoxylin-
eosin (HE) (Leica) and immunohistochemistry staining as
described (41). For immunohistochemistry of histology slides the
following antibodies were used: anti-TER-119 (R&D Systems,
MAB1125) and Alexa Fluor 488 conjugated goat anti-rat
IgG antibody (Life Technologies A11006). Stained slides were
mounted with Vectashield DAPI Mounting Medium (Vector
Laboratories, H-1200). Tissue section samples were imaged using
a Nikon Ni-U upright microscope (Nikon Instruments) using a
40x dry objective connected to a Nikon DS-Ri2 camera.
Whole-Mount Immunostaining of
Meninges, Image Acquisition and Analysis
Dissected meninges were incubated in PBS containing 10% of
goat or horse serum for 1 h at room temperature followed
by staining with antibodies against LYVE-1 (R&D Systems,
AF2125), PROX-1 (Abcam, ab76696), PDPN (Abcam, ab92319),
PECAM (R&D Systems, MAB3628), F4/80 (BioLegend, 123101).
For the visualization of GFP and YFP in our transgenic
lymphatic reporter mouse models anti-GFP antibody (Life
Technologies, A11122) was used. All primary antibodies were
diluted at 1:170 in the presence of 10% serum and 0.1%
Tween 20, and were incubated for 24 h at 4◦C. Thereafter,
samples were incubated with Alexa Fluor 488/568/594 anti-
rabbit/anti-goat/anti-rat/anti-syrian hamster IgG antibodies (Life
Technologies, A21206, A11055, A11057, A11006, A11077,
A21113) at 1:1000. Then whole-mount tissues were washed
in PBS. Control immunostainings were used for all primary
antibodies as it is represented in Supplementary Figure 1.
Images of whole-mount samples were acquired by a Nikon
SMZ-25 stereo microscope (Nikon Instruments) connected to
a Nikon DS-Ri2 camera or a Nikon Eclipse Ti2 microscope
(Nikon Instruments) using a 10x dry objective connected
to a Yokogawa CSU-W1 confocal scanner unit (Yokogawa
Electric Corporation). Quantitative assessments including the
length and area measurements were performed using NIS
Elements software.
Structure of the meningeal lymphatic vessels was assessed
using a clinical score system on a 0–15 scale by two independent
investigators blinded for all parameters (genotype, age etc.) of the
mice. The scoring system is based on continuity of meningeal
lymphatic vessels (0–4 points; 0 point: totally discontinuous
lymphatic structure; 4 points: continuous lymphatic structures);
structural malformations of the meningeal lymphatics (0–3
points; 0 point: numerous severe structural malformations;
3 points: intact meningeal lymphatic structures); presence of
lymphatic vessels adjacent to the superior sagittal sinus (0–2
points; 0 point: no lymphatic vessels adjacent to the superior
sagittal sinus; 1 point: lymphatic vessels on one side of the
superior sagittal sinus; 2 points: lymphatic vessels on both sides of
the superior sagittal sinus), transverse sinus (0–2 points; 0 point:
no lymphatic vessels adjacent to the transverse sinus; 1 point:
lymphatic vessels adjacent to the transverse sinus on one side of
the skull; 2 points: lymphatic vessels adjacent to the transverse
sinus on both sides of the skull), and the middle meningeal
arteries (0–2 points; 0 point: no lymphatic vessels adjacent to the
middle meningeal arteries; 1 point: lymphatic vessels adjacent to
the middle meningeal arteries on one side of the skull; 2 points:
lymphatic vessels adjacent to the middle meningeal arteries on
both sides of the skull); and number of branching points (0–
2 points; 0: no branches or max. 3 branches; 1 point: 3 to
10 branches; 2 points: more than 10 branches). Mean of the
values given by the two independent investigators was used for
each mouse.
Characterization of Meningeal Lymphatic
Function
For monitoring meningeal lymphatic function 2.5 µl of 70 kDa
Rhodamine-labeled dextran (RhD) (Life Technologies, D1818),
40 kDa RhD (Life Technologies, D1842), 3 kDa RhD (Life
Technologies, D3308) from a 10 mg/ml stock and PBS were
injected into the dorsal prefrontal cortex of the right hemisphere,
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cisterna magna or subcutaneously to mice anesthetized with
2.5% Avertin (Sigma-Aldrich, T48402). For intraparenchymal
injection, a midline skin incision was made to reveal the skull
bone, which was thinned 2mm lateral and 1.5mm caudal to the
bregma. 2.5 µl of the tracers were slowly injected into ∼2mm
depth with a Hamilton syringe using a blunt-ended 30G needle
for 3min. The needle was slowly removed after the mouse was
left in position for 5min to prevent leakage. For intra cisterna
magna injection, the neckmuscles were bluntly dissected through
a small midline incision and 70 kDa RhD was slowly injected
into the cisterna magna with a Hamilton syringe using a sharp-
ended 32G needle for 3min. The needle was slowly removed
after the mouse was left in position for 5min to prevent leakage.
Subcutaneous injection was performed at the same injection
site which was used for the intraparenchymal injection. The
injection of the macromolecules was rigorously controlled in
each experiment. Importantly, the injection site was carefully
examined in every experimental animal. If the injection was
not successful, the mouse was excluded from the dataset. For
intraparenchymal injection of E17.5 embryos, pregnant female
mice were anesthetized and 2.5 µl of 70 kDa RhD was injected
through the uterine wall into the dorsal prefrontal cortex of the
right hemisphere of each embryo by a 30G needle. Needle was
removed 2min post injection. Experimental mice or embryos
between E17.5 and P21 were sacrificed 100min post injection and
drainage of the injected labeledmacromolecules to themeningeal
lymphatic vessels and lymph nodes in the cervical region was
assessed by fluorescent stereo microscopy in combination with
LEC-specific immunostaining. Drainage of the fluorescently
labeled molecules into the cervical lymph nodes were quantified
by measuring the mean fluorescent intensity of the area of
the lymph nodes (mean fluorescent intensity of background
subtracted from the mean fluorescent intensity of lymph nodes)
using NIS Elements software. The drainage to the cervical area
was also assessed in live mice.
Characterization of the Gut Phenotype of
Plcγ2−/− and Littermate Control Mice
To characterize the gut lymphatic phenotype of PLCγ2-
deficient and littermate control mice a clinical score system
was used on a 0–4 scale by two independent investigators
blinded for all parameters (genotype, age etc.) of the mice.
The following parameters were included: the blood filling and
structural malformations of lymphatic vessels in the mesentery
and small intestine (0 or 1 point for each parameter). For
quantification a mean of the values given by the two independent
investigators was used for each mouse. Plcγ 2−/− mice with
points more than 2.5 were considered as displaying severe
gut phenotype.
Monitoring the Presence of Blood in the
Regional Lymph Nodes of Plcγ2−/− and
Littermate Control Mice
To monitor the presence of blood in the regional lymph nodes
a score system was used on a 0–4 scale by two independent
investigators blinded for all parameters (genotype, age etc.)
of the mice (0–no blood in the lymph node, 4–total area
of lymph node is filled with blood). Mean of the values
given by the two independent investigators was used for
each mouse.
Characterization of Lymphatic Function in
the Small Intestine of Plcγ2−/− and
Littermate Control Mice
To monitor lymphatic function in the small intestine, mice
were fasted overnight followed by feeding them with 100 µl
of 4,4-Difluoro-5,7-Dimethyl-4-Bora-3a,4a-Diaza-s-Indacene-3-
Hexadecanoic Acid (BODIPY C16) (Thermo Fisher, D3821)
diluted in sunflower oil (Sigma-Aldrich, S5007) at 1:250. Two
hours later, mice were sacrificed and imaged by fluorescent
stereo microscopy.
Monitoring the Lymphatic Function in the
Hind Limb of Plcγ2−/− and Littermate
Control Mice
To monitor lymphatic function in the hind limb, subcutaneous
injection of 2.5 µl 10 mg/ml 70 kDa RhD was performed into
the hind limb paws of young adult mice anesthetized with 2.5%
Avertin (41). Mice were sacrificed 100min post injection and
drainage of the injected labeled macromolecules was assessed by
fluorescent stereo microscopy.
Presentation of the Data and Statistical
Analysis
Experiments were performed the indicated number of times.
For all experiments, investigators were blinded for the origin
of mice and treatment from the time of euthanasia to the
end of the analysis. Quantitative graphs show mean and
SEM. Statistical analyses were performed using Graph Pad
Prism 7.0 and Microsoft Office Excel software programs.
Specific statistical tests are presented in the figure legend
for each experiment. P-values below 0.05 were considered
statistically significant.
RESULTS
Lymphatic Vessels Are Present in the Dura
Mater
First, we visualized the expression pattern of lymphatic markers
in the meningeal compartment. LYVE-1, PDPN and PROX-
1 positive LECs were detectable along the transverse and
sagittal sinuses in young adult (P21) C57BL/6 wild type mice
(Figures 1A–D). These structures also carry the PECAM
panendothelial marker (Figure 1A). Prox1GFP and Flt4YFP
lymphatic reporter animals, which express GFP or YFP in all
PROX-1 or VEGFR3 positive LECs, show fluorescent signal
adjacent to the transverse and sagittal sinuses overlapping
with LYVE-1 and PECAM molecules shown by fluorescent
stereo microscopy and confocal imaging (Figures 1E–I).
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FIGURE 1 | Expression of lymphatic markers in meninges of young adult mice. (A) Expression pattern of PECAM and LYVE-1 shown in the dura mater of young adult
wild type mice (n = 7). Bars, 500µm. (B,C) LYVE-1 and PDPN immunostaining of mouse meninges imaged by fluorescent stereo microscopy (n = 12; bars, 500µm)
(B) or confocal imaging (n = 3; bars, 100µm) (C). (D) LYVE-1 and PROX-1 immunostaining of meninges (n = 4). Bars, 500µm. (E–G) Expression pattern of GFP,
LYVE-1 and PECAM adjacent to the venous sinuses of the meninges of Prox1GFP lymphatic reporter mice at P21. Images are shown for native GFP signal (n = 5;
bars, 500µm) (E), GFP and LYVE-1 immunostaining detected by fluorescent stereo microscopy (n = 6; bars, 500µm) (F) or confocal microscopy (n = 3; bars,
200µm) (G). (H) Expression pattern of GFP and PECAM shown by fluorescent stereo microscopy after whole-mount immunostaining of wild type meninges (n = 5).
Bars, 500µm. (I) Expression of YFP and LYVE-1 adjacent to the venous sinuses of the meninges of young adult Flt4YFP lymphatic reporter mice shown by GFP and
LYVE-1 immunostaining (n = 3). Bars, 500µm. Representative images are shown in all panels.
These studies confirmed the presence of lymphatics in the
dura mater.
Meningeal Lymphatics Take Up and
Transport Macromolecules From the CNS
The contribution of meningeal lymphatic structures to the
transport of macromolecules from the CNS is not clear.
While the results of one part of the research groups indicate
the involvement of meningeal lymphatics in the transport of
large molecules from the CNS, other investigators are not so
convinced or were not able to demonstrate the role of meningeal
lymphatic vessels in the process (6, 7, 10, 11, 20). The widely
used approach for monitoring the transport of macromolecules
from the CNS is injecting labeled molecules into the brain
parenchyma, ventricles, or cisterna magna. Our results indicate
that fluorescently labeled 70 kDa RhD is detectable adjacent
to the sinuses after intraparenchymal injection in LYVE-1
positive meningeal lymphatic vessels in young adult animals
and in Flt4YFP mice in the VEGFR3 positive lymphatic vessels
(Figures 2A,B).
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FIGURE 2 | Uptake and transport of fluorescently labeled macromolecules
injected into the CNS by the meningeal lymphatic vessels. (A,B) Monitoring
the uptake and transport of 70 kDa RhD by the meningeal lymphatic vessels
shown in whole-mount stained meninges of young adult wild type mice using
the LYVE-1 marker (A) and YFP signal in Flt4YFP lymphatic reporter mice (B)
imaged by fluorescent stereo microscopy after intraparenchymal injection with
70 kDa RhD. Representative images are shown of 3 independent experiments.
White arrowheads show RhD in the meningeal lymphatic vessels. Bars,
500µm.
Meningeal Lymphatics Develop During the
Postnatal Period, Which Process Involves
Their Structural Maturation
Next, we characterized the developmental program of meningeal
lymphatics. Meningeal lymphatics exhibit a fully mature
morphology by P21 along the transverse and sagittal sinuses
shown by Prox1-GFP, Flt4-YFP, LYVE-1, PDPN, and PECAM
markers (Figures 3A–E). Between P0 and P21 a structural
remodeling and maturation process of the primary network
occurs as it is shown in Prox1GFP and Flt4YFP lymphatic
reporter mice and by the immunostaining of lymphatic and
panendothelial markers (Figures 3A–G). At P0 a premature
structure can be detected expressing Prox1-GFP, Flt4-YFP and
PDPN markers, which structure is surrounded by LYVE-1
positive single cells, and the expression of LYVE-1 and F4/80
are detectable in these single cells adjacent to the developing
lymphatic network shown by fluorescent stereo microscopy and
confocal imaging (Figures 3H–J). The number of these LYVE-1
positive cells is reduced by P21, while several F4/80 positive single
cells are still present (Figures 3H–J).
Macromolecules Injected Into the CNS Are
Transported to the Deep Cervical Lymph
Nodes
Next, we monitored the transport of fluorescently labeled
macromolecules from the CNS to the cervical lymph nodes in
experimental mice. 70, 40, and 3 kDa RhD conjugates were
injected into the brain parenchyma and cisterna magna. In
parallel, intraparenchymal injection of PBS and subcutaneous
injection of 70 kDa RhD (at the same injection site which was
used for the intraparenchymal injections) were also performed
as controls. Minimal drainage of the fluorescent tracers was
detected to the superficial cervical lymph nodes compared to
the controls (Figure 4A). In contrast, the transport of the
labeled 70 and 40 kDa macromolecules was robust to the deep
cervical lymph nodes after intraparenchymal and cisterna magna
injections (Figure 4B). The quantification of the drainage also
revealed the significant and strong drainage of the fluorescent
macromolecules to the deep cervical lymph nodes after
parenchymal and cisterna magna injections (Figure 4C). The
drainage of macromolecules after intraparenchymal injection
showed ipsilateral dominance (Figure 4C). Macromolecule
drainage to the cervical area after intraparenchymal (or intra
cisterna magna) injections of the fluorescently labeled tracers
in live animals was also monitored at various time points (data
not shown). The fluorescent macromolecules were detectable in
the deep cervical lymph nodes after 30min, and there was an
increase in the fluorescent signal by 120min in live animals
(data not shown). These experiments revealed no difference
compared to the studies when the animals were sacrificed just
before performing fluorescent microscopy.
The Structural Remodeling of the
Meningeal Lymphatic Vessels Coincides
With the Increase of the Transport of
Macromolecules to the Deep Cervical
Lymph Nodes
To characterize the drainage of macromolecules from the CNS
to the cervical area, intraparenchymal injection of 70 kDa RhD
was performed between P0 and P21. The transport of the
labeled macromolecule was robust at P21 to the deep cervical
lymph nodes, dominantly to the injection side (Figures 5A–C).
In contrast, the drainage was reduced at earlier time points,
and almost no drainage was detected at P0 (Figures 5B,C).
Quantitative data also showed that the drainage of the labeled
macromolecule is increasing between P0 and P21 (Figure 5C).
The transport of the labeled macromolecules to the cervical
region is also not detectable after the intraparenchymal injection
of the E17.5 embryos in utero (Figure 5D). These results indicate
that the efficient transport of macromolecules to the deep cervical
lymph nodes coincides with the maturation of the meningeal
lymphatic network (shown in Figure 3).
Characterization of the Phenotype of
Plcγ2−/− Embryos and Mice Induced by
Backflow of Blood Into the Lymphatic
System
We aimed to characterize the role of the mechanical forces
generated by lymph flow as possible regulators of the
developmental program of meningeal lymphatics. It is known
that mouse models lacking the components of the CLEC2, SYK,
SLP76, PLCγ2 signaling pathway in platelets develop backflow of
blood from the venous system into the lymphatics (31–33, 35).
This phenotype is present because of the loss of platelet activation
by LECs at the lympho-venous junction, where the thoracic duct
meets the subclavian vein. In prior reports CLEC2-deficient
mice were used to define the role of lymphatic function in the
gut and lung (25, 36, 37). To characterize the phenotype of
PLCγ2-deficient embryos, the strain was crossed to the Flt4YFP
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FIGURE 3 | Characterization of the developmental program of meningeal lymphatics. (A) Expression of GFP and LYVE-1 adjacent to the venous sinuses of
whole-mount immunostained meninges of Prox1GFP lymphatic reporter mice at P0 and P21 (P0 n = 9; P21 n = 6). Bars, 500µm. (B) Expression of GFP and PDPN
(Continued)
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FIGURE 3 | adjacent to the venous sinuses of whole-mount immunostained meninges of Prox1GFP lymphatic reporter mice at P0 and P21 (P0 n = 6; P21 n = 6).
Bars, 500µm. (C) Expression of YFP and LYVE-1 in the dura mater of Flt4YFP lymphatic reporter mice detected by whole-mount immunostaining at P0 and P21 (P0 n
= 6; P21 n = 3). Bars, 500µm. (D) LYVE-1 and PDPN expression shown in the meninges of P0 and P21 wild type mice (P0 n = 8; P21 n = 8). Bars, 500µm.
(E) PECAM and LYVE-1 expression adjacent to the superior sagittal sinus at P0, P3, P5, P8, P13 and P21 in wild type mice (P0 n = 6; P3 n = 5; P5 n = 2; P8 n = 2;
P13 n = 3; P21 n = 7). Bars, 500µm. (F) GFP signal detected by fluorescent stereo microscopy (n = 18) in meninges of Prox1GFP lymphatic reporter mice at P0.
Bars, 500µm. (G) GFP and LYVE-1 expression detected by confocal microscopy after whole-mount immunostaining of meninges of Prox1GFP lymphatic reporter
mice at P0. Bars, 200µm. (H,I) LYVE-1 and F4/80 expression shown in the meninges of wild type mice at P0 and P21 imaged by fluorescent stereo microscopy (P0 n
= 9; P21 n = 6; bars, 500µm) (H) or confocal imaging (bars, 200µm) (I). (J) GFP and F4/80 expression in the meninges of P0 and P21 Prox1GFP reporter mice (P0 n
= 3; P21 n = 3). Bars, 500µm. Representative images are shown in all panels.
lymphatic reporter background. The mesenteric lymphatic
vessels are blood-filled and a premature network of mesenteric
lymphatic vessels is present in Plcγ 2−/− embryos during late
gestation compared to Plcγ 2+/+ and Plcγ 2+/− littermates,
indicating the defective structural maturation of mesenteric
lymphatic vessels (Figures 6A,B), which process is lymph
flow-dependent and also detectable in the absence of CLEC2
(25, 36). These findings suggest that the lymph flow is reduced in
PLCγ2-deficient embryos similarly to CLEC2-deficient model.
Next, we defined the survival rate of PLCγ2-deficient mice
at weaning age. Only 9.9% of the knockouts (the Mendelian
expected ratio is 25 %) were alive at this age (Figure 6C),
most likely because of the impairment of pulmonary lymphatic
function in the embryonic lung (41). As expected, blood-filled
lymphatics were present in the intestinal wall and mesentery
of surviving Plcγ 2−/− animals compared to Plcγ 2+/+ and
Plcγ 2+/− littermate control mice at P21 (Figure 6D). In these
experiments Plcγ 2−/− mice with severe or less severe (mild) gut
phenotype were detected (Figure 6D) similarly to the CLEC2-
deficient and SLP76-deficient models as described before (32,
42). Plcγ 2−/− animals showing mild phenotype at P21 have
less blood-filled lymphatic vessels in the mesentery and gut
wall compared to the Plcγ 2−/− animals displaying severe gut
phenotype (Figure 6D). Thereafter, the severity of the phenotype
was assessed in Plcγ 2−/−, Plcγ 2+/+ and Plcγ 2+/− littermate
control mice using a score system, and we set up two separate
groups of Plcγ 2−/−mice displaying severe or mild gut phenotype
(Figure 6E).
We also characterized the structure of the lymph nodes
in Plcγ 2+/+, Plcγ 2+/− and Plcγ 2−/− littermates (Figure 6F
and Supplementary Figure 2). The mesenteric, inguinal
and superficial cervical lymph nodes are blood-filled in
the model, which is caused by the backflow of the blood
(Supplementary Figure 2) as it was reported by others in
CLEC2-deficient mice (31, 32). It is also important to note that
the deep cervical lymph nodes are not or minimally blood-filled
in Plcγ 2−/− mice (Figure 6F and Supplementary Figure 2).
This is similar to the phenotype of the lymph nodes of the lung
which are also not blood-filled in CLEC2-deficient animals, but
the lymphatic function is still greatly reduced in them (37). It
is not known why backflow of blood is more complete in the
intestine than in the lung or deep cervical lymph nodes, but
the fact that the deep cervical lymph nodes in PLCγ2-deficient
animals contain no or minimal blood makes the model even
better. It is important to appreciate the lymph nodes and vessels
without blood in their lumen still experience the reduced
lymphatic flow because they feed into more proximal vessels that
are obstructed by the backflow of blood from the venous system
[as it was shown in (32)]. Moreover, our studies indicate that the
basic structure of lymph nodes in Plcγ 2−/− mice was not altered
(Supplementary Figure 2B).
Reduced Lymphatic Function and Lymph
Flow in Plcγ2−/− Mice
Next, we characterized the lymphatic function in various organs
in PLCγ2-deficient mice. Lymphatic function and lymph flow
are critical in lipid absorption from the small intestine. First,
fluorescently labeled lipid (BODIPY C16) was used to feed
PLCγ2-deficient mice to assess the lymphatic function in the gut.
As it is shown in Figure 7A normal transport of the fluorescently
labeled lipid was visualized in Plcγ 2+/+ and Plcγ 2+/− mice, but
there was no detectable lymphatic function in Plcγ 2−/− mice
with severe gut phenotype. Please note that the transport of the
fluorescently labeled lipid was less reduced in Plcγ 2−/− mice
with mild gut phenotype.
Second, as a large molecule 70 kDa RhD was injected into
the hind paw, and the lymph flow of the hind limb was
monitored and the drainage to the lymph nodes was assessed
(Figure 7B). The lymphatic function was greatly impaired
in Plcγ 2−/− mice with severe gut phenotype, and it was
less reduced in Plcγ 2−/− mice with mild gut phenotype
(Figure 7B).
Third, the drainage of labeled macromolecules from the
CNS after intraparenchymal or intra cisterna magna injection
was assessed in Plcγ 2+/+ and Plcγ 2−/− littermates. While the
transport to the deep cervical lymph nodes in Plcγ 2+/+ mice
was significant both after intraparenchymal and intra cisterna
magna injections, it was greatly reduced in Plcγ 2−/− mice with
severe gut phenotype (Figures 7C,D). The quantification of the
data also indicates significant drainage to the deep cervical
lymph nodes in control mice, and reduced transport in Plcγ 2−/−
littermates with severe gut phenotype (Figures 7E,F). Of note,
the drainage of the labeled macromolecules was less reduced
to the deep cervical lymph nodes in Plcγ 2−/− mice displaying
less severe phenotype in the mesentery and small intestine
after intraparenchymal and intra cisterna magna injections
(Figures 7E,F). Collectively, these findings indicate that the
reduction of the lymphatic function and lymph flow correlates
with the gut phenotype of the animals. If the gut phenotype is less
severe, the lymph flow is less reduced.We believe that similarly to
the previous reports using the CLEC2-deficient strain referenced
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FIGURE 4 | Monitoring the drainage of macromolecules from the CNS to the superficial and deep cervical lymph nodes. (A,B) Accumulation of the injected labeled
macromolecules in the superficial cervical lymph nodes (A) and deep cervical lymph nodes (B) of lymphatic reporter mice after intraparenchymal injection of 70, 40
and 3 kDa RhD, PBS, intra cisterna magna injection of 70 kDa RhD and subcutaneous injection of 70 kDa RhD at the same injection site which was used for the
intraparenchymal injections (n = 6 for 70 kDa RhD intraparenchymal injection; n = 4 for 40 kDa RhD intraparenchymal injection; n = 4 for 3 kDa RhD intraparenchymal
injection; n = 4 for PBS intraparenchymal injection; n = 2 for 70 kDa intra cisterna magna injection; n = 4 for 70 kDa RhD subcutaneous injection). Bars, 1,000µm.
Representative images are shown. (C) Quantitative data are shown for mean fluorescent intensity in the lymph nodes of the cervical region (mean fluorescent intensity
of background subtracted from the mean fluorescent intensity of lymph nodes) compared to PBS injection (One-way ANOVA, Dunnett’s post-hoc test; mean ± SEM;
n = 3 or more animals for each group; n = 6 for 70 kDa RhD intraparenchymal injection; n = 4 for 40 kDa RhD intraparenchymal injection; n = 4 for 3 kDa RhD
intraparenchymal injection; n = 4 for PBS intraparenchymal injection; n = 2 for 70 kDa intra cisterna magna injection n = 4 for 70 kDa RhD subcutaneous injection;
*P < 0.05 vs. intraparenchymal PBS injection; **P < 0.01 vs. intraparenchymal PBS injection; ****P < 0.0001 vs. intraparenchymal PBS injection).
Frontiers in Immunology | www.frontiersin.org 9 January 2020 | Volume 10 | Article 3043
Bálint et al. Lymph Flow-Mediated Maturation of Meningeal Lymphatics
FIGURE 5 | Monitoring the drainage of macromolecules from the CNS during the first three postnatal weeks. (A,B) Drainage of 70 kDa RhD into the superficial
cervical lymph nodes (A) and deep cervical lymph nodes (B) of lymphatic reporter mice at P0, P3, P5, P8, P13 and P21 after intraparenchymal injection (P0 n = 3; P3
n = 3; P5 n = 4; P8 n = 4; P13 n = 6; P21 n = 6). Bars, 1,000µm. (C) Quantitative data for mean fluorescent intensity in the deep cervical lymph nodes (mean
fluorescent intensity of background subtracted from the mean fluorescent intensity of lymph nodes) after intraparenchymal injection of 70 kDa RhD into lymphatic
reporter animals at P0, P3, P5, P8, P13 and P21 (One-way ANOVA, Dunnett’s post-hoc test; mean ± SEM; n = 3 or more animals for each group; P0 n = 3; P3 n =
3; P5 n = 4; P8 n = 4; P13 n = 6; P21 n = 6; *P < 0.05 vs. P21; **P < 0.01 vs. P21). (D) Drainage of 70 kDa RhD into the superficial and deep cervical lymph nodes
of Flt4YFP reporter mice at E17.5 after in utero intraparenchymal injection (n = 2). Bars, 1,000µm. Representative images are shown.
in (25, 36, 37), we have established an excellent model to study
the possible role of lymph flow in in vivo experiments.
Lymph Flow-Induced Structural Maturation
and Remodeling of the Meningeal
Lymphatic Vessels
Next, we characterized the morphology of the meningeal
lymphatics in animals with reduced lymphatic function and
lymph flow. Surprisingly, the structural development of the
meningeal lymphatic vessels was impaired in Plcγ 2−/− mice
displaying severe gut phenotype shown by immunostaining
of LYVE-1-PECAM and LYVE-1-PDPN markers at P21
(Figures 8A–D). The defect in the structural maturation of
meningeal lymphatics was less severe in the Plcγ 2−/− mice
showing mild gut phenotype at P21 (Figures 8A,C), but LYVE-
1-PECAM and LYVE-1-PDPN staining of lymphatic markers
revealed a dramatic impairment of the maturation process
in Plcγ 2−/− mice displaying severe gut phenotype at P21
(Figures 8B,D). The evaluation of the images using a score
system for the maturation process and length measurements
of meningeal lymphatic vessels also revealed the correlation
between the impaired maturation process of meningeal
lymphatics and the severity of the altered lymphatic function
and gut phenotype in the genetic model (Figures 8E–H). The
defect of the structural maturation of meningeal lymphatics
was also demonstrated by confocal imaging using LYVE-1
immunostaining (Figure 8I). Please note the presence of several
LYVE-1 positive single cells next to the superior sagittal sinus
in Plcγ 2−/− mice displaying severe gut phenotype but not in
Plcγ+/+ mice at P21 (Figure 8I). Of note, at P0 there is no
significant difference in the expression pattern of the markers
immunostained with PECAM and LYVE-1 markers in Plcγ 2−/−
mice (Figure 8J). Collectively, these findings indicate that lymph
flow may act as an important regulator of the maturation and
structural remodeling of meningeal lymphatics.
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FIGURE 6 | Characterization of the lymphatic phenotype of Plcγ2−/− and littermate control mice. (A) Lymphatic and blood vessels are shown
in the wall of small intestine and mesentery of Plcγ2+/+, Plcγ2+/− and Plcγ2−/− embryos at E19.5 (n= 6 for Plcγ2+/+ embryos; n= 7 for Plcγ2+/− embryos, n= 6 for
(Continued)
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FIGURE 6 | Plcγ2−/− embryos). Bars, 500µm. (B) Fluorescent stereo microscopic images are shown of YFP-positive lymphatic vessels of the gut wall and mesentery
of Plcγ2+/+, Plcγ2+/− and Plcγ2−/− embryos at E19.5 on a Flt4YFP lymphatic reporter background (n = 3 for Plcγ2+/+ embryos; n = 3 for Plcγ2+/− embryos; n = 3
for Plcγ2−/− embryos). Bars, 500µm. (C) Genotype of the offsprings of Plcγ2 colony at weaning age compared to Mendelian distribution. Contingency table and
stacked bar graph are shown. Pearson’s Chi-square test was performed for testing equality of percentile profiles of allele pairs distribution of 373 offsprings from 67
litters of Plcγ2+/− × Plcγ2+/− matings at weaning age compared to Mendelian allele pairs distribution. *P < 0.05. (D) Images of lymphatic and blood vessels in the
small intestine and mesentery are shown of young adult Plcγ2+/+, Plcγ2+/− and Plcγ2−/− mice with mild or severe gut phenotype (n = 26 for Plcγ2+/+, n = 9 for
Plcγ2+/−, n = 9 for Plcγ2−/− mice with mild gut phenotype, n = 18 for Plcγ2−/− mice with severe gut phenotype). Yellow arrowheads point to mesenteric lymphatic
vessels. Bars, 1,000µm. All images are representative. (E) Quantitative data are shown for clinical scores for blood-filling and malformations of lymphatics in the
mesentery and small intestine of Plcγ2+/+, Plcγ2+/− and Plcγ2−/− mice with mild or severe gut phenotype (Mean ± SEM; One-way ANOVA; Dunnett’s post-hoc
test; n = 26 for Plcγ2+/+, n = 9 for Plcγ2+/−, n = 9 for Plcγ2−/− mice with mild gut phenotype, n = 18 for Plcγ2−/− mice with severe gut phenotype; ****P <
0.0001 vs. Plcγ2+/+). (F) Clinical scores for presence of blood in lymph nodes of inguinal lymph nodes, superficial cervical lymph nodes and deep cervical lymph
nodes of young adult Plcγ2+/+, Plcγ2+/− and Plcγ2−/− mice with mild or severe gut phenotype are shown (0 point: no blood filling of lymph node detected; 4 points:
severe blood filling of lymph node; One-way ANOVA, Dunnett’s post-hoc test; mean ± SEM; n = 2 or more animals for each group; Inguinal lymph nodes: n = 6 mice
for Plcγ2+/+, n = 3 mice for Plcγ2+/−, n = 2 mice for Plcγ2−/− mice with mild gut phenotype, n = 3 mice for Plcγ2−/− mice with severe gut phenotype; Cervical
lymph nodes: n = 11 mice for Plcγ2+/+, n = 3 mice for Plcγ2+/−, n = 4 mice for Plcγ2−/− mice with mild gut phenotype, n = 7 mice for Plcγ2−/− mice with severe
gut phenotype; *P < 0.05 vs. Plcγ2+/+; **P < 0.01 vs. Plcγ2+/+; ***P < 0.001 vs. Plcγ2+/+; ****P < 0.0001 vs. Plcγ2+/+). Representative images are shown.
Defective Maturation of Meningeal
Lymphatics Affects the Uptake and
Transport of Macromolecules From the
CNS
Thereafter, the uptake of macromolecules into the meningeal
lymphatic vessels was characterized in Plcγ 2+/+ and
Plcγ 2−/− littermate mice. The uptake and transport of labeled
macromolecules were detected into the meningeal lymphatic
vessels in Plcγ 2+/+ mice at P21 after intraparenchymal injection
(Figure 9A), similarly as it was shown in Figure 2. In contrast,
the process was impaired in Plcγ 2−/− mice displaying severe
gut phenotype (Figure 9A). Moreover, the uptake of the labeled
macromolecule was less impaired in Plcγ 2−/− mice displaying
mild gut phenotype (Figure 9A). Of note, the highly intense
spots near the transverse sinus are also present not only in
the Plcγ 2+/+ but also in the Plcγ 2−/− animals (Figure 9A).
Confocal imaging also revealed normal uptake and transport of
fluorescently labeled macromolecules in Plcγ 2+/+ mice after
intraparenchymal or intra cisterna magna injections, while the
structure of meningeal lymphatics was greatly impaired and the
macromolecule transport was not present in Plcγ 2−/− mice
displaying severe gut phenotype (Figures 9B,C).
DISCUSSION
We demonstrated the presence of LYVE-1, PROX-1, VEGFR3,
PDPN and PECAM positive lymphatic structures in the dura
mater (Figure 1), which results are in accordance with former
reports (6, 7, 10, 11, 21). We also described that meningeal
lymphatics develop during the postnatal period (Figure 3) as it
was reported by others (21, 22). However, we show the presence
of a premature network surrounded by single cells, which might
be a lymphangiogenic LYVE-1 positive cell population that may
contribute and help the maturation process of the meningeal
lymphatic network (Figure 3). The presence and possible role of
a single cell population during the process of lymphangiogenesis
was also reported by others, but further detailed studies will
be needed to understand how they are involved in this process
(21, 22).
Our results indicate that meningeal lymphatic structures
are involved in the uptake and transport of macromolecules
from the CNS (Figures 2, 9). While one part of the prior
reports (mostly published by the Kipnis group) indicate that
meningeal lymphatics participate in the transport of large
molecules from the CNS, other studies were not able to detect
the transport of macromolecules by meningeal lymphatics and
indicated that further studies are needed to define their role
in macromolecule and leukocyte transport (6, 7, 10, 11, 20).
Our results support the concept of that meningeal lymphatics
are likely players in the transport of macromolecules from the
CNS, providing an independent confirmation of the uptake.
After our submission another paper has been published in which
the authors performed intraparenchymal and intra cisterna
magna infusions of the labeled macromolecules, and also
detected the uptake and drainage by the meningeal lymphatics
(19). Most of the prior studies have been performed after
euthanasia of animals, because monitoring the macromolecule
transport by the meningeal lymphatics in the intact skull is
technically challenging and may have limitations, which prevent
the effective detection of the uptake and transport by the
meningeal lymphatic structures. In connection, Ma et al. using an
elegant approach demonstrated the drainage of macromolecules
injected into the CNS to the deep cervical lymph nodes via
several different transport routes including the paravascular
space of the pia mater and perineural routes in live animals,
but the involvement of meningeal lymphatics was unclear based
on their work (20), which is in contrast to the findings of
others (6, 10). As another aspect, a recent paper by Ma et al.
indicated the backflow of the labeled tracer from the CSF to
the brain after sacrificing the animals (but not in live mice),
which was an unexpected finding because it contradicts the
current view (43). Based on this study it is possible that
sudden loss of systemic blood pressure after euthanasia may
change the macromolecule and fluid movements between the
vasculature and the interstitium, which may also influence the
detection of the uptake of macromolecules by the meningeal
lymphatics. Of note, the uptake of macromolecules into the
meningeal lymphatics after euthanasia is not mentioned in that
study (43). All the approaches discussed above have limitations
because all require the injection of a labeled tracer molecule.
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FIGURE 7 | Characterization of lymphatic function in Plcγ2−/− and littermate control mice. (A) Representative images are shown for uptake and drainage of BODIPY
C16 by mesenteric lymphatic vessels of young adult Plcγ2
+/+, Plcγ2+/− and Plcγ2−/− mice with mild or severe gut phenotype 2 h after feeding with BODIPY C16.
(Continued)
Frontiers in Immunology | www.frontiersin.org 13 January 2020 | Volume 10 | Article 3043
Bálint et al. Lymph Flow-Mediated Maturation of Meningeal Lymphatics
FIGURE 7 | Yellow arrowheads point to lymphatic vessels draining BODIPY C16 (n = 6 mice for Plcγ2
+/+, n = 3 mice for Plcγ2+/−, n = 2 mice for Plcγ2−/− mice
with mild gut phenotype, n = 2 mice for Plcγ2−/− mice with severe phenotype). (B) Representative images are shown for uptake and drainage of 70 kDa RhD
100min after subcutaneous injection to hind limb paws of young adult Plcγ2+/+, Plcγ2+/− and Plcγ2−/− mice with mild or severe gut phenotype. Purple arrowheads
show RhD signal in popliteal lymph nodes (n = 6 mice for Plcγ2+/+, n = 3 mice for Plcγ2+/−, n = 2 mice for Plcγ2−/− mice with mild gut phenotype, n = 2 mice for
Plcγ2−/− mice with severe gut phenotype). (C,D) Images shown for drainage of 70 kDa RhD into the deep cervical lymph nodes after intraparenchymal injection of
the fluorescently labeled macromolecule to Plcγ2+/+ and Plcγ2−/− mice with severe gut phenotype on a Flt4YFP lymphatic reporter background (C) or injection of the
tracer into cisterna magna of Plcγ2+/+ and Plcγ2−/− mice with severe gut phenotype (D) (n = 5 for intraparenchymal injection; n = 2 for intra cisterna magna
injection). Bars, 1,000µm. All images are representative. (E) Quantitative data are shown for mean fluorescent intensity in the deep cervical lymph nodes (mean
fluorescent intensity of background subtracted from the mean fluorescent intensity of lymph nodes) after intraparenchymal injection of 70 kDa RhD into Plcγ2+/+ and
Plcγ2−/− mice with severe or mild phenotype in the gut (Mean ± SEM; One-way ANOVA; Dunnett’s post-hoc test; n = 8 for Plcγ2+/+ mice; n = 3 for Plcγ2−/− mice
with mild gut phenotype, n = 5 for Plcγ2−/− mice with severe gut phenotype; *P < 0.05 vs. Plcγ2+/+; **P < 0.01 vs. Plcγ2+/+; ***P < 0.001 vs. Plcγ2+/+; ****P <
0.0001 vs. Plcγ2+/+). (F) Quantitative data are shown for drainage to the deep cervical lymph nodes (mean fluorescent intensity of background subtracted from the
mean fluorescent intensity of lymph nodes) after intra cisterna magna injection of 70 kDa RhD into Plcγ2+/+ and Plcγ2−/− mice with severe or mild phenotype in the
gut (Mean ± SEM; One-way ANOVA; Dunnett’s post-hoc test; n = 3 for Plcγ2+/+ mice; n = 1 for Plcγ2−/− mice with mild gut phenotype, n = 2 for Plcγ2−/− mice
with severe gut phenotype).
An important step forward would be for the whole field to
develop a model (e.g., a transgenic mouse) in which the labeled
macromolecule is released and secreted directly into the CNS,
therefore, the model would not require the injection of the
labeled tracer.
The paravascular flow of macromolecules in the neural tissue
of the brain is mediated by the glymphatic system (13). However,
it is an important question how the meningeal lymphatic vessels
are connected to the glymphatic system of the CNS. Our findings
in accordance with other reports suggest that some dedicated,
special locations close to the transverse sinus are crucial for the
formation of the connection between the separate compartments
(Figures 2, 9). In recent publications very similar locations were
called as “hot spots” by others (10, 19). Further studies using
special in vivo imaging techniques will be needed to determine
the possible mechanisms how these spots connect the meningeal
lymphatics to the CNS.
Our results revealed that the drainage of macromolecules
injected into the CNS is mediated to the deep cervical lymph
nodes after intraparenchymal or intra cisterna magna injections
(Figure 4). This result was expected based on the former
published works, the drainage of fluorescent tracers from the
brain parenchyma has been extensively studied (6, 7, 15–
17, 44). Similarly to us, others also detected the draining
of macromolecules to both deep cervical lymph nodes (or
retropharyngeal lymph nodes) after intraparenchymal injection
(or intracortical injection) in adult experimental animals. In
these reports a marginal ipsilateral preference of the drainage
was described, which difference was not always reported as
significant (7, 44, 45). It is important to note that in addition
to the drainage of large molecules by the meningeal lymphatics
other possible routes of this drainage process are known
including the paravascular spaces of the pia mater and other
perineural routes (e.g., next to the optic nerve) (20). Further
studies are needed to determine the relative contribution of
the meningeal lymphatics and the other possible routes to
the drainage of macromolecules from the CNS. It is also
not known how the meningeal lymphatics exit the skull and
how they are connected to the cervical region. A recent
report demonstrated that meningeal lymphatics at the skull
base are important to mediate the connection (19). It is also
possible that the meningeal lymphatics anastomose with other
drainage routes.
Importantly, in this study we compared the transport of
the labeled macromolecules from the CNS to the maturation
process of the meningeal lymphatics (Figure 5). Our results
indicate a close correlation between the two processes suggesting
that structural maturation of the developing lymphatic network
might be an important mechanism to mediate and maintain the
effective drainage of macromolecules from the brain.
It has been defined that mechanical forces and shear stress
generated by lymph flow are critical regulators of lymphatic
endothelial cell gene expression, lymphatic growth and the
maturation of the lymphatic network in vitro and in vivo
(24–30). It is well-accepted that in the mouse models lacking
the components of the CLEC2, SYK, SLP76 signaling axis in
platelets there is backflow of blood from the venous system
into the lymphatic system (31–33). This phenotype develops
because of the loss of platelet activation by lymphatic endothelial
cells at the lympho-venous junction, where the thoracic duct
meets the subclavian vein. Studies using the CLEC2-deficient
genetic model in which the lymph flow is reduced due to the
backflow of blood into the lymphatic system indicated that
lymph flow is an essential mechanical regulator of the maturation
and remodeling of a premature lymphatic network during the
developmental process in the mesentery of the gut (25, 36).
In another recent report CLEC2-deficient mice with reduced
lymphatic function were used to define the role of pulmonary
lymphatics in the postnatal lung (37). PLCγ2 is a component
of the same CLEC2, SYK, SLP76 signaling axis with similar
phenotype (blood-filled lymphatics in embryos etc.) (34). Here
we have performed the detailed analysis of the lymph flow
in several organs of the PLCγ2-deficient mice. Our studies
revealed reduced lymphatic function in the small intestine and
hind limb in PLCγ2-deficient mice (Figures 7A,B). In addition,
impairment of the drainage of labeled macromolecules was
detected from the CNS after intraparenchymal and intra cisterna
magna injections to the deep cervical lymph nodes in Plcγ 2−/−
mice (Figures 7C,D). Our results indicate that the lymphatic
function is greatly reduced in the hind limb, small intestine
and cervical lymph nodes connected to the CNS in Plcγ 2−/−
mice. Moreover, the reduction of the flow correlates with the
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FIGURE 8 | Morphological characterization of the meningeal lymphatics in Plcγ2+/+ and Plcγ2−/− mice. (A,B) Images are shown of PECAM and LYVE-1 expression
in the meninges of young adult Plcγ2−/− and Plcγ2+/+ mice with mild (A) or severe (B) gut phenotype (n = 8 for Plcγ2+/+ mice; n = 3 for Plcγ2−/− mice with mild
(Continued)
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FIGURE 8 | gut phenotype; n = 4 for Plcγ2−/− mice with severe gut phenotype). Bars, 500µm. (C,D) Images are shown of LYVE-1 and PDPN expression next to the
transverse sinus and superior sagittal sinus of Plcγ2+/+ (n = 8), Plcγ2−/− mice with mild (n = 3) (C) and severe (n = 6) (D) gut phenotype. Bars, 1,000µm. (E)
Quantitative data are shown for clinical scores (0–15) representing structural malformations of the meningeal lymphatics in Plcγ2+/+ and Plcγ2−/− mice with severe or
mild phenotype in the gut (Mean ± SEM; One-way ANOVA; Dunnett’s post-hoc test; n = 15 for Plcγ2+/+ mice; n = 5 for Plcγ2−/− mice showing mild gut phenotype,
n = 11 for Plcγ2−/− mice displaying severe gut phenotype; **P < 0.01 vs. Plcγ2+/+). (F–H) Quantitative data are shown for differences in the total length of the
meningeal lymphatics (F), total length of the meningeal lymphatics adjacent to the superior sagittal sinus (G), and adjacent to the transverse sinuses (H) in Plcγ2+/+
and Plcγ2−/− mice displaying severe or mild phenotype in the gut (Mean ± SEM; One-way ANOVA; Dunnett’s post-hoc test; n = 15 for Plcγ2+/+ mice; n = 5 for
Plcγ2−/− mice showing mild gut phenotype, n = 11 for Plcγ2−/− mice displaying severe gut phenotype; *P < 0.05 vs. Plcγ2+/+; **P < 0.01 vs. Plcγ2+/+; ***P <
0.001 vs. Plcγ2+/+). (I) Confocal images are shown of LYVE-1 and F4/80 immunostaining of whole-mount meninges of young adult Plcγ2+/+ and Plcγ2−/− mice
with a severe gut phenotype (n = 3 for each group). Bars, 200µm. (J) Images are shown of PECAM and LYVE-1 expression in the meninges of Plcγ2+/+ and
Plcγ2−/− mice with severe gut phenotype at P0 (n = 5 for both groups). Bars, 500µm. All images are representative.
FIGURE 9 | Uptake and transport of labeled macromolecules by the meningeal lymphatics in Plcγ2+/+ and Plcγ2−/− mice. (A) Uptake and transport of 70 kDa RhD
by the meningeal lymphatic vessels after intraparenchymal injection of young adult Plcγ2+/+, Plcγ2−/− mice displaying mild or severe gut phenotype. Representative
images are shown of whole-mount anti-LYVE-1 immunostaining of meninges of young adult mice (n = 8 for Plcγ2+/+ mice; n = 3 for Plcγ2−/− mice showing mild gut
phenotype, n = 5 for Plcγ2−/− mice displaying severe gut phenotype). Purple arrowheads point to spots with a high intensity for macromolecule uptake, white
arrowheads show meningeal lymphatic vessels draining RhD. Bars, 1,000µm. (B,C) Confocal images are shown of region adjacent to the superior sagittal sinus of
whole-mount immunostained meninges of young adult Plcγ2+/+ and Plcγ2−/− mice after intraparenchymal (B) or intra cisterna magna (C) injection of 70 kDa RhD
(intraparenchymal injection: n = 3 for Plcγ2+/+ mice; n = 3 for Plcγ2−/− mice displaying severe gut phenotype; intra cisterna magna injection: n = 3 for Plcγ2+/+
mice; n = 2 for Plcγ2−/− mice displaying severe gut phenotype). White arrowheads show meningeal lymphatic vessels draining RhD. Bars, 200µm.
gut phenotype of the animals (Figures 6, 7), indicating that if
the gut phenotype is less severe, the lymph flow is less reduced.
This is in accordance with former studies, which reported that
the backflow of blood can be less severe in some animals, and the
phenotype correlates with the impairment of lymph flow (32, 42).
Collectively, we believe that we have established a good model
to study the possible role of lymph flow in in vivo experiments
similarly to the previous reports using the CLEC2-deficient
strain (25, 36, 37).
Using PLCγ2-deficient mouse strain displaying reduced
lymphatic function in various organs we revealed that the
remodeling and maturation of meningeal lymphatic structures
that occurs during the postnatal period is flow-mediated and
flow-dependent (Figure 8). It should be noted that the defect in
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this maturation process is less severe in animals showing mild
gut phenotype, which result further supports the importance
of the increasing lymph flow during the development and
maturation of the structures (Figure 8). Moreover, the uptake
and transport of the labeled macromolecules by the meningeal
lymphatics were also affected in animals with impaired lymph
flow, while high intensity spots [referred as “hot spots” by
others (10)] were still visible in Plcγ 2−/− mice (Figure 9).
These findings support that these high intensity spots might
be key sites where the connection between the meningeal
lymphatics and brain is formed, but to understand the detailed
mechanism further studies will be needed. In addition, the
defect in the transportation of macromolecules by the meningeal
lymphatics was less severe in Plcγ 2−/− animals showing mild
gut phenotype (Figure 8C), which finding further supports
our conclusions.
Taken together, our studies indicate that meningeal
lymphatics are involved in the transport of macromolecules
from the CNS. Importantly, lymph flow induced mechanical
forces are required for the postnatal formation of mature
and functional meningeal lymphatic vessels, which process
coincides with increase of drainage of macromolecules
from the CNS. Our studies revealing the lymph flow
mediated regulation of the development and function of
meningeal lymphatics may lead to better understanding
of the pathogenesis of neurological diseases such as
Alzheimer’s disease and neuroinflammatory diseases including
multiple sclerosis.
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Supplementary Figure 1 | Representative images of control immunostainings of
meninges. Whole-mount immunostaining and control immunostaining of samples
for LYVE-1, PDPN, PROX-1, PECAM, GFP and F4/80 in the dura mater of wild
type, Prox1GFP and Flt4YFP mice. (A,B) Representative images are shown for
PECAM and LYVE-1 immunostaining (A) and LYVE-1 and PROX-1 immunostaining
(B) of meninges of mice. Bars, 500µm. (C) Representative images are shown for
GFP and PECAM immunostaining of meninges of Prox1GFP mice. Bars, 500µm.
(D) Representative images are shown for LYVE-1 and PDPN immunostaining of
meninges of mice. Bars, 1,000µm. (E,F) Representative images are shown for
GFP and LYVE-1 immunostaining of meninges of Flt4YFP (E) and Prox1GFP (F)
mice. Bars, 500µm. (G) Representative images are shown for LYVE-1 and F4/80
immunostaining of meninges of mice. Bars, 500µm. (H) Representative native
fluorescent stereo microscopic images are shown for native GFP signal in isolated
meninges of Prox1GFP and littermate control mice. Bars, 500µm.
Supplementary Figure 2 | Characterization of lymph nodes in Plcγ2−/− and
littermate control mice. (A) Representative stereo microscopic images of
mesenterial lymph nodes, inguinal lymph nodes, superficial cervical lymph nodes
and deep cervical lymph nodes of young adult Plcγ2+/+, Plcγ2+/− and Plcγ2−/−
mice with mild or severe gut phenotype (n = 11 mice for Plcγ2+/+, n = 3 mice for
Plcγ2+/−, n = 4 mice for Plcγ2−/− mice with mild gut phenotype, n = 7 mice for
Plcγ2−/− mice with severe phenotype). Purple arrowheads point to lymph nodes.
Bars, 1,000µm. (B) Representative histological images of lymph nodes are shown
by Haematoxylin-Eosin staining (n = 3 mice for Plcγ2+/+, n = 2 mice for
Plcγ2+/−, n = 1 for Plcγ2−/− mice with mild gut phenotype, n = 1 for Plcγ2−/−
mice with severe gut phenotype). Bars, 50µm. (C) Representative images are
shown for presence of erythrocytes in lymph nodes detected by fluorescent
TER-119 immunostaining of lymph node samples isolated from young adult
Plcγ2+/+, Plcγ2+/− and Plcγ2−/− mice with mild or severe gut phenotype (n = 3
mice for Plcγ2+/+, n = 2 mice for Plcγ2+/−, n = 1 for Plcγ2−/− mice with mild
gut phenotype, n = 1 for Plcγ2−/− mice with severe gut phenotype). Bars, 50 µm.
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